Molecular iodine promoted synthesis of new pyrazolo [3, 4-d] pyrimidine derivatives as potential antibacterial agents
… Author links open overlay panel Mehdi Bakavoli a , Ghodsieh Bagherzadeh b , Maryam
Vaseghifar b , Ali Shiri a , Mehdi Pordel a , Mansour Mashreghi c , Parvaneh Pordeli c …
Vaseghifar b , Ali Shiri a , Mehdi Pordel a , Mansour Mashreghi c , Parvaneh Pordeli c …
Time-dependent computed tomographic perfusion thresholds for patients with acute ischemic stroke
… based on discrete or continuous time analysis (P>0.05). A statistically significant relationship
… flow (P<0.001; r=0.59 and 0.77 for gray and white matter, respectively) and T max (P<0.001; …
… flow (P<0.001; r=0.59 and 0.77 for gray and white matter, respectively) and T max (P<0.001; …
[HTML][HTML] Rituximab versus mycophenolate mofetil in patients with pemphigus vulgaris
…, L Gearhart, A Kapre, P Pordeli… - … England Journal of …, 2021 - Mass Medical Soc
Background Rituximab and mycophenolate mofetil are used to treat pemphigus vulgaris,
but they have not been adequately compared in clinical trials. Methods In a randomized, …
but they have not been adequately compared in clinical trials. Methods In a randomized, …
Regional comparison of multiphase computed tomographic angiography and computed tomographic perfusion for prediction of tissue fate in ischemic stroke
CD d'Esterre, A Trivedi, P Pordeli, M Boesen, S Patil… - Stroke, 2017 - Am Heart Assoc
… with all CTP models (P>0.05). Mean Tmax and cerebral blood volume values were
significantly different between each washout score (P<0.01) and each delay score category (P<0.01). …
significantly different between each washout score (P<0.01) and each delay score category (P<0.01). …
Time for a time window extension: insights from late presenters in the ESCAPE trial
JW Evans, BR Graham, P Pordeli… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The safety and efficacy of endovascular therapy for large-artery
stroke in the extended time window is not yet well-established. We performed a …
stroke in the extended time window is not yet well-established. We performed a …
[PDF][PDF] Fe(HSO4)3 as an Efficient Catalyst for Diazotization and Diazo Coupling Reactions
…, MM Matin, F Oroojalian, P Pordeli - Journal of the Korean …, 2012 - researchgate.net
… Among all screened compounds, entries 1 and 5 exhibited a good antibacterial activity
against the P. aeruginosa whereas entry 6 showed a good antibacterial activity against S. aureus …
against the P. aeruginosa whereas entry 6 showed a good antibacterial activity against S. aureus …
[PDF][PDF] Phase IIa global study evaluating rituximab for the treatment of pediatric patients with granulomatosis with polyangiitis or microscopic polyangiitis
…, C Bracaglia, D Eleftheriou, P Pordeli… - Arthritis & …, 2022 - Wiley Online Library
Objective To assess the safety, tolerability, pharmacokinetics, and efficacy of rituximab (RTX)
in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis …
in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis …
[PDF][PDF] Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis
…, JL Niles, LE Mertz, PB Lehane, P Pordeli… - Arthritis Care & …, 2021 - Wiley Online Library
Objective The present study was undertaken to conduct a phase IV, open‐label, prospective
study to characterize the long‐term safety of rituximab in a 4‐year observational registry of …
study to characterize the long‐term safety of rituximab in a 4‐year observational registry of …
Preparation, characterization and antibacterial activity of manganese oxide nanoparticles
…, R Etefagh, M Mashreghi, P Pordeli - Physical Chemistry …, 2015 - physchemres.org
Manganese oxide nanoparticles (Mn3O4-NPs) were prepared using precipitation method.
The prepared nanoparticles were characterized by a number of techniques, including X-ray …
The prepared nanoparticles were characterized by a number of techniques, including X-ray …
Synthesis and evaluation of antibacterial activity of new derivatives of pyrimido[4,5-e][1,3,4]oxadiazine
… Mehdi Bakavoli 1,*, Mohammad Rahimizadeh 1, Ali Shiri 1, Hossein Eshghi 1, Simin
Vaziri-Mehr 2, Parvaneh Pordeli 3 and Mohsen Nikpour 4 … Bakavoli, M.; Bagherzadeh, G.; …
Vaziri-Mehr 2, Parvaneh Pordeli 3 and Mohsen Nikpour 4 … Bakavoli, M.; Bagherzadeh, G.; …